MEDP vs IQV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 31, 2026

MEDP

62.3
AI Score
VS
MEDP Wins

IQV

62.2
AI Score

Investment Advisor Scores

MEDP

Jul 31, 2026
62score
Recommendation
BUY

IQV

Jul 31, 2026
62score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric MEDP IQV Winner
Forward P/E 31.6456 19.0114 IQV
PEG Ratio 3.2688 0.9791 IQV
Revenue Growth 17.2% 8.7% MEDP
Earnings Growth 37.1% -0.6% MEDP
Tradestie Score 62.3/100 62.2/100 MEDP
Profit Margin 17.7% 8.1% MEDP
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation BUY BUY Tie

Relative Price Performance (Last 90 Days)

MEDP 1M: +2.8% · 3M: +37.3% IQV 1M: +12.7% · 3M: +47.9%

Current Technical Phase

MEDP

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (12.0% over 20 days), RSI 60

RSI (14): 59.8 · Price: $573.29

IQV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.5% over 20 days), RSI 66

RSI (14): 66.5 · Price: $233.36

Fundamentals Snapshot

Metric MEDP IQV
Market Cap
Forward P/E 29.7 16.2
Trailing P/E 33.9 29.2
Revenue (TTM)
Revenue Growth 0.2% 0.1%
Gross Margin 0.7% 0.3%
Operating Margin 0.2% 0.1%
EPS 17.01 8.04
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MEDP is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.